The third annual ICBO 2012 conference will be held in succession with the 7^th annual International Conference on Formal Ontology in Information Systems at the Medical University of Graz, Austria. Goldfain has the opportunity to present his research at the 2012 conference, which will be hosted as an Early Career Symposium designed to give PhD students and postdoctoral researchers a chance to present their research. In addition to presenting his work, Goldfain’s paper will be published in a symposium booklet.

The conference will be hosted from July 21-25, 2012. For more information about ICBO 2012, please visit ICBO/FOIS 2012.

The mission of the Biotechnology Symposium is to bring together industry representatives and scientists, academics and students, and other professionals interested in biotechnology in order to develop synergies and relationships that further advance the field. In addition, the symposium seeks to stimulate interest in the CNY Biotechnology Research Center, the region’s new bio-incubator facility.

This year’s symposium will feature information sessions on Bioenergy, Drug Delivery and Nanotechnology, Stem Cells and Tissue Engineering, Biopharmaceuticals.

For more information on how to register for the 2012 Biotechnology Symposium, please visit http://www.esf.edu/outreach/pd/2012/biotechnology.

To learn more about how Blue Highway can help you, please contact us.

Di Rienzo’s session topics included remote patient monitoring, state-of-the-art telehealth, nursing informatics, and the future of telemedicine. The goal of his session was to discuss the multiple uses of telemedicine and the applications of telehealth in a clinical setting. In addition, Di Rienzo described the current uses of telepsychiatry by nurses with individuals with developmental disabilities statewide.

The RRTI will present a total of 11 Nurse Training Program sessions across New York State, all with a focus on training nurses in pharmacology, telemedicine, and developmental disabilities. The program offers these classes for free, as the funding is provided by the Health Resources and Services Administration (HRSA) of the United States Department of Health and Human Services. For more information or how to register, visit www.rrti.org

Di Rienzo discussed some of the current projects worked on by the Blue Highway team. Researchers are working with Welch Allyn to develop a non-invasive, early, visual screening test predictor for Alzheimer’s. This screener will be able to detect visual bio markers prior to the onset of the disease. Blue Highway is taking game-changing ideas through proof of concept and clinical studies.

The culture at Blue Highway is what allows creativity and innovation to flow. There is a freedom to incubate idea and foster ingenuity, while everyone is working toward the same goal, the betterment of society. No one employee is isolated as everyone is willing to be collaborative. For more information about Blue Highway, click here.

To listen to Al’s conversation about Blue Highway, please click the following links:

Part 1           Part 2            Part 3

• SMART: Smart devices will eliminate the mental and physical steps of transcribing data into patient medical records. Communication failures and human errors in care delivery will be drastically reduced.
• CONNECTED: As health insurance becomes nearly universal, a Smart device will make information more accessible, optimize disease management, identify best practices, and educate patients about their health status. Resources will be used more efficiently and sustainably, producing better health outcomes at all levels of care.
• CONTEXTUAL: A Smart device will be able to perform a situational analysis of the patient at a given time. Providing the proper context in a healthcare situation greatly reduces the margin of error and eliminates fallacies.

Di Rienzo will have the opportunity to offer courses and lectures, and work in collaboration with both students and faculty from the Institute. The professorship was appointed by James Spencer, Associate Dean for Science, Mathematics, and Research and Executive Director of FNSSI, in concurrence with George Langford, Dean of the College of Arts and Sciences at Syracuse University. For more information about the Forensic and National Security Sciences Institute, visit forensics.syr.edu

About Blue Highway, Inc.

Since its founding in 2008, Blue Highway has been affiliated with Syracuse University. Blue Highway is an industry-leading healthcare and technology company, specializing in the research, engineering, and commercialization of novel ideas. Through an advanced triage process across many disciplines, Blue Highway provides clients with translational services. In addition to specializing in the medical and healthcare fields, Blue Highway is experienced in sensing, signal processing, and advanced analytics.

Di Rienzo’s presentation, titled “Innovation Success Story: Frameworks for Fast Tracking Innovation”, will address the difficulties regrading translation from research to commercialization and how it can be achieved within diverse corporate settings. Di Rienzo will also discuss a case history, examples of successful innovations and how to avoid the pitfalls of establishing an innovation environment. The presentation is scheduled for 10 a.m. on Tuesday, March 13.

Di Rienzo will also participate in The Executive Panel Discussion, “mHealth: Are You Ready to Be a Driver of the Future?” on Monday, March 12. For more information regarding the event or for the opportunity to register, click here.

About Frost & Sullivan
Frost & Sullivan is a research and consulting firm that enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership.

The Future of Health Technology Summit is an annual event that brings together health and technology experts to share and debate ideas about cutting-edge medical technologies. The event will run from September 26-27, 2011 at the MIT Faculty Club in Cambridge, M.A.

Di Rienzo will be addressing the future of the medical device industry in his presentation, Anticipating Changes in Medical Device Industry in 2025 and Beyond, scheduled for the first morning session. Goldfain, who will present during the first afternoon session, will discuss what could happen if medical devices could peek into a patient’s health record.

The summit will cover a wide array of topics, including online care; intelligent caring machines; music therapy; early disease detection; wellness; deep semantic models of medicine; extending human sensing to nano-level; artificial organs; ending aging; virtual nurses enhanced by haptics; the future of rehabilitation; the future of personal status monitoring and cryopreservation.

About The Future of Health Technology Institute
The Future of Health Technology Institute in Hopkinton, Mass., is the health technology think tank dedicated to defining the health technology agenda for the 21st century. The institute was established to identify the most promising technologies to improve the quality of health care and to define promising health technology research areas needed to meet future health challenges. For further information, visit the Web site at www.fhti.org.

PSM, which stands for Personal Status Monitor, is a wearable computing platform that collects accelerometer data, along with heart rate and respiration vital signs. The primary goals of this project are to develop the PSM so that it can accurately and automatically categorize the user’s kinetic/postural and health states; efficiently store categorized data into persistent repositories; and design efficient longitudinal pattern recognition algorithms to query and compute over data repositories.

Dr. Goldfain is a computer science researcher at Blue Highway involved in researching pattern classification, communications protocols, context-sensitive computing and the application of biomedical ontologies to interoperable medical device networks.